OABI
OmniAb is a therapeutic antibody discovery company that provides access to diverse antibody repertoires and cutting-edge screening technologies to enable discovery of next-generation therapeutics. Its in vivo transgenic platforms generate high-quality, fully human antibodies, enabling access to challenging targets. The company supports biopharmaceutical collaborations from its headquarters in Emeryville, California, and emphasizes partnerships and advanced technologies such as OmniRat, OmniMouse, OmniChicken, OmnidAb, OmniUltra, OmniTaur, and xPloration screening.
No recent news for this company.
No recent deals for this company.